The feminine hygiene market is worth $15 billion, a whopping number that makes sense as millions upon millions of women have their period regularly each month. Thinx is a company that’s out for blood. They are revolutionizing the sector by offering new period-proof underwear. So ladies, when it’s the time of the month, now you … Continue reading “Period Proof Underwear Could Be The New Craze”
Biotech & Pharma
Biotech & Pharma
Tesaro (TSRO) Shares Double On Cancer Drug Success
You know champagne bottles are being popped open when your cancer drug treatment trial ends…
June 29, 2016
Biotech & Pharma
AstraZeneca (AZN) Battles Crestor Competition
AstraZeneca recently received FDA approval to use Crestor, its blockbuster cholestrol drug, to treat children…
June 29, 2016
Biotech & Pharma
This New Vaccine Could Treat Multiple Sclerosis
Multiple Sclerosis is one of the most severe diseases in the neurodegenartive autoimmune family. Protective…
June 27, 2016
Biotech & Pharma
Ackman’s New Video Has Herbalife (HLF) Shares Popping
Billionaire investor William Ackman has made it no secret that he is against Herbalife, the…
June 21, 2016
Biotech & Pharma
Cat Allergy Sent This Pharma Company Plummeting
British biotech company Circassia Pharmaceuticals sank on Monday after its experimental cat allergy treatment failed…
June 20, 2016
Biotech & Pharma
This Common Cancer Treatment May Disappear
It makes absolutely no sense for an effective cancer treatment to vanish from the market,…
June 16, 2016
Biotech & Pharma
Your Hot Tea Could Cause Cancer
Just when we thought the list couldn't get any longer. One more thing has just…
June 15, 2016
Biotech & Pharma
This New Drug Could Help Psoriasis Sufferers
Between 2 to 4 percent of the population suffers from Psoriasis and those who have…
June 13, 2016
Biotech & Pharma
Cantabio Pharmaceuticals Inc. (CTBO) Targets Alzheimer’s
More than 700,000 seniors are expected to die this year from Alzheimer's disease. It is…
June 8, 2016
Biotech & Pharma
Overdosing On Anti-diarrhea Drugs.. Yeah, It’s A Thing
Most of us realize we are in an epidemic when it comes to overdosing on…
June 8, 2016
Biotech & Pharma
Carl Icahn Gives In To Botox By Buying Stake In Allergan (NYSE: ACT)
Just a decade after it initially hit the market, Botox is one of the most…
May 31, 2016
Biotech & Pharma
Aeterna Zentaris Inc. (NASDAQ: AEZS) Is Trading Far From Last Year’s Highs
Just a year ago, shares of Aeterne Zentaris were trading at $52.50. Today the stock…
May 27, 2016
Biotech & Pharma
Could This Superbug Take Us All Out?
Pretty soon we are all going to need to walk around in bubbles given how…
May 27, 2016